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During cell entry, reovirus particles disassemble to generate ISVPs. ISVPs undergo conformational
changes to form ISVP* and this conversion is required for membrane penetration. In tissues where ISVP
formation occurs within endosomes, ISVP-to-ISVP* conversion occurs at low pH. In contrast, in tissues
where ISVP formation occurs extracellularly, ISVP-to-ISVP* transition occurs at neutral pH. Whether
these two distinct pH environments inﬂuence the efﬁciency of cell entry is not known. In this study, we
used Ouabain to lower the endosomal pH and determined its effect on reovirus infection. We found that
Ouabain treatment blocks reovirus infection. In cells treated with Ouabain, virus attachment, inter-
nalization, and ISVP formation were unaffected but the efﬁciency of ISVP*s formation was diminished.
Low pH also diminished the efﬁciency of ISVP-to-ISVP* conversion in vitro. Thus, the pH of the
compartment where ISVP-to-ISVP* conversion takes place may dictate the efﬁciency of reovirus
infection.
& 2015 Elsevier Inc. All rights reserved.
Introduction
Viruses can cross the host cell membrane barrier at the plasma
membrane or from within intracellular compartments such as
endosomes (Yamauchi and Helenius, 2013). The site of membrane
bypass is largely governed by the presence of host factors needed
for virus entry. For those viruses that enter cells via the endocytic
compartment, virus entry is often dependent on the low pH
environment of the endocytic pathway. For enveloped viruses
such as inﬂuenza A virus (IAV) or vesicular stomatitis virus
(VSV), low pH can trigger conformational changes in the viral
glycoprotein and consequently permit fusion of viral and host
membranes (White et al., 1981). For nonenveloped viruses such as
adenovirus and rhinovirus, low pH can promote conformational
changes in the viral capsid that allow exposure of the membrane-
penetration machinery (Brabec et al., 2003; Greber et al., 1993).
Some viruses such as Ebola virus, require the activity of low-pH
dependent endosomal proteases for priming the envelope glyco-
proteins for membrane fusion (Chandran et al., 2005). Similarly,
for nonenveloped viruses such as the mammalian reovirus, low
pH-dependent proteases mediate disassembly of the viral capsid
to expose membrane-active components (Ebert et al., 2002;
Martinez et al., 1996; Sturzenbecker et al., 1987). The pH of the
endocytic compartment progressively decreases from early
endosomes (pH 6.8–6.0) to late endosomes (pH 6.0–5.0) to
lysosomes (pHo5.0) (Ohkuma and Poole, 1978; Tycko and
Maxﬁeld, 1982). Thus, the pH at which viral machinery for cell
entry is optimally active determines when the virus exits the
endocytic pathway (Lozach et al., 2011). Thus, viruses such as IAV,
that require lower pH (5.5–5.1) to complete events required for
crossing the host membrane, exit the endocytic pathway from late
endosomes whereas those, such as Semliki Forest virus (SFV), that
require a less acidic pH (6.0) exit the endocytic pathway from
early endosomes (Lozach et al., 2010; White et al., 1981). In this
study, we investigated how pH affects the reovirus cell penetration
machinery and if it impacts the efﬁciency with which reovirus
cores exit the endocytic pathway.
Particles of reovirus are comprised of two concentric protein
shells, the outer-capsid and the inner core (Dryden et al., 1993).
The reovirus core encapsidates 10 segments of dsRNA along with
enzymes necessary for generating viral mRNA. The outer-capsid of
reovirus is comprised of three major proteins (σ1, σ3 and μ1),
which function at different stages of cell entry. Reovirus initiates
infection by binding to carbohydrate and proteinaceous receptors
on the host cell via the σ1 protein (Barton et al., 2001a, 2001b;
Dermody et al., 1990; Reiss et al., 2012). Following attachment, the
virus is internalized into endosomes via clathrin- or caveolin-
mediated endocytosis (Boulant et al., 2013; Ehrlich et al., 2004;
Maginnis et al., 2008; Schulz et al., 2012). Within cellular endo-
somes, the reovirus capsid is disassembled by the action of acid
pH-dependent cathepsin B and L proteases (Ebert et al., 2002;
Martinez et al., 1996; Sturzenbecker et al., 1987). The viral σ3
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protein is completely digested by cathepsins resulting in exposure
of the μ1 membrane penetration protein (Ebert et al., 2002).
Cathepsins also cleave the μ1 protein into two particle-
associated fragments, μ1δ and ϕ. This partially disassembled
particle is referred to as the infectious subvirion particle (ISVP)
(Baer et al., 1999; Borsa et al., 1973; Chang and Zweerink, 1971;
Ebert et al., 2002; Silverstein et al., 1972; Sturzenbecker et al.,
1987). ISVPs then undergo a conformational change, likely trig-
gered by a host membrane component to form ISVP*s (Chandran et
al., 2002). ISVP* formation is characterized by autocleavage of the
μ1 protein near the N terminus to generate μ1N and by the release
of μ1N and ϕ (Chandran et al., 2002; Ivanovic et al., 2008; Nibert
et al., 2005). μ1N functions with ϕ to form pores in membranes,
which are necessary for delivery of the viral core into the
cytoplasm to continue the viral replication cycle (Agosto et al.,
2006; Ivanovic et al., 2008; Odegard et al., 2004).
The exact compartment in which each of the reovirus cell entry
events take place is not known. Reovirus disassembly is blocked by
lysomotropic agents such as ammonium chloride and Baﬁlomycin
A1 that prevent the lowering of endosomal and lysosomal pH
(Martinez et al., 1996; Sturzenbecker et al., 1987). Cathepsin
proteases are most active in late endosomes and lysosomes
(Turk et al., 2012). Based on the requirement for transport of virus
to the late endosomes and the requirement for low-pH dependent
cathepsin activity for virus infection (Ebert et al., 2002; Mainou
and Dermody, 2012; Martinez et al., 1996; Sturzenbecker et al.,
1987), it is assumed that ISVP formation occurs in late endosomes.
Under these conditions, ISVP* formation occurs in a low pH
compartment. In some tissues, such as the intestinal tract or
respiratory tract, reovirus disassembly can occur extracellularly
(Bass et al., 1990; Bodkin et al., 1989; Nygaard et al., 2012). Serine
proteases present in the lumen of these tissues can generate ISVPs
by degradation of σ3 and cleavage of μ1 (Bass et al., 1990; Bodkin
et al., 1989; Nygaard et al., 2012). ISVPs generated extracellularly
can initiate infection even in the presence of lysomotropic agents
(Martinez et al., 1996; Sturzenbecker et al., 1987). Moreover, they
initiate infection at the plasma membrane or following internali-
zation but prior to reaching the early endosomes (Borsa et al.,
1979; Boulant et al., 2013; Lucia-Jandris et al., 1993; Schulz et al.,
2012). Thus, ISVP* formation after infection is initiated by ISVPs
occurs under neutral or near-neutral conditions. Though determi-
nants that control ISVP-to-ISVP* formation have been extensively
studied (Agosto et al., 2007, 2008; Chandran et al., 2002, 2003;
Coffey et al., 2006; Madren et al., 2012; Middleton et al., 2007;
Sarkar and Danthi, 2010, 2013), all of these studies have analyzed
ISVP* formation in vitro, at neutral pH.
Toward the goal of assessing the effect of pH on the function of
the reovirus membrane penetration apparatus, we sought to alter
the pH of the endosomal compartment. Blocking endosomal
acidiﬁcation prevents ISVP formation (Martinez et al., 1996;
Sturzenbecker et al., 1987), and therefore would not allow us to
determine the effect of pH on membrane penetration steps that
occur subsequent to ISVP formation. We therefore elected to
increase the acidity of the endosomal compartment. Endosomal
pH is controlled by the vacuolar ATPase (Forgac, 2007; Van Dyke,
1996). The function of the vacuolar ATPase is dependent on the
positive charges present in the lumen of the endosome (Rudnick,
1986). Positive charge within the endosome is controlled by the
electrogenic Naþ/Kþ pump (Cain et al., 1989; Fuchs et al., 1989).
Disruption of the function of Naþ/Kþ pump by agents such as
Ouabain octahydrate (referred to as Ouabain) further lowers the
pH of the endosomes (Cain et al., 1989; Feldmann et al., 2007). We
therefore tested the effect of Ouabain on the capacity of reovirus to
initiate infection of host cells. We observed that further acidiﬁca-
tion of cellular endosomes using Ouabain diminishes the efﬁcie-
ncy of virus infection. A decrease in pH does not affect virus
attachment, uptake, or ISVP formation but blocks conversion of
ISVPs to ISVP*s. These data indicate that the reovirus cell penetra-
tion apparatus is sensitive to pH. Thus, the pH of the compartment
from which reovirus initiates infection can inﬂuence the efﬁciency
of infection.
Results
Ouabain blocks reovirus infection
To test the effect of Ouabain on reovirus infection, cells were
infected with two virus strains T1L and T1L/T3DM2 in the
presence of increasing concentrations of Ouabain for 18 h. T1L
and T1L/T3DM2 contain an identical σ1 attachment protein but
distinct μ1 proteins (Sarkar and Danthi, 2010). Thus, these two
viruses should be expected to trafﬁc via the same route but it is
anticipated that T1L/T3DM2 will exit the endosomal compartment
with greater efﬁciency than T1L (Chandran et al., 2002; Lucia-
Jandris et al., 1993; Sarkar and Danthi, 2010). Using indirect
immunoﬂuorescence to detect reovirus antigen, we observed a
dose-dependent decrease in cells positive for reovirus proteins
following infection with each reovirus strain (Fig. 1A). These data
suggest that Ouabain treatment affects reovirus infectivity. To rule
out the possibility that the inhibitory effect of Ouabain on reovirus
infection is restricted to L929 cells, we assessed the effect of
Ouabain on reovirus infection of CHO cells (Fig. 1B). We observed
that Ouabain was also inhibitory to infection by both viruses in
CHO cells. Because Ouabain blocked infection by both viruses in
two different cell lines with equivalent efﬁcacy, we performed the
remainder of our experiments with T1L/T3DM2 in L929 cells.
We next measured the capacity of Ouabain to affect the
production of infectious reovirus following a single round of
replication. We observed a 2.2 log10 increase in reovirus titer over
24 h following infection in control cells (Fig. 1C). In contrast, only a
1.3 log10 increase in viral titer was observed in the presence of
Ouabain (Fig. 1C). To ensure that the inhibitory effect of Ouabain
on reovirus infection was not due to deleterious effect on cell
division or due to toxicity to cells, we determined if Ouabain
altered intracellular ATP levels in uninfected cells (Crouch et al.,
1993; Saunders et al., 2014). We observed no difference in the
intracellular ATP levels in Ouabain-treated and control cells
(Fig. 1D) indicating that Ouabain treatment did not alter metabolic
activity in the treated cells. Uninfected cells treated with 0 or
500 μM Ouabain also did not demonstrate any obvious difference
in morphology (Fig. 1E). These data indicate that Ouabain does not
compromise cell health and suggest that Ouabain treatment has
an inhibitory effect on reovirus replication.
Ouabain does not affect virus attachment or uptake into a low pH
compartment
To identify how Ouabain affects reovirus replication, we
assessed the effect of Ouabain on each stage of virus replication.
Using ﬂow cytometry, we compared both the number of cells
staining positive for cell-associated reovirus (% reovirus-positive
cells) and the amount of virus bound to each cell (Mean ﬂuores-
cence intensity, MFI) in the presence or absence of Ouabain. Under
the conditions used, we found that 70–80% of control and
Ouabain-treated cells were reovirus positive and each displayed
a MFI of 500–600 (Fig. 2A). These data indicate that Ouabain
does not inﬂuence reovirus attachment.
Following attachment to host cells, reovirus particles are
internalized by clathrin- or caveolin-mediated endocytosis into
early endosomes (Boulant et al., 2013; Ehrlich et al., 2004;
Maginnis et al., 2008; Schulz et al., 2012). To determine whether
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Ouabain treatment affects endocytosis of reovirus, we allowed
internalization of attached reovirus particles for 3 h and imaged
infected cells using confocal microscopy. Reovirus particles were
found internalized in both untreated and Ouabain treated cells.
Quantiﬁcation of internalization indicated that the extent of inte-
rnalization was not affected by the presence of Ouabain (Fig. 2B).
Following internalization, particles traverse through early and late
endosomal compartments prior to delivery of viral cores into the
cytoplasm (Mainou and Dermody, 2012). Thus, the virus is
delivered into a low pH compartment. To determine if Ouabain
treatment inﬂuences uptake and delivery of reovirus particles into
a low pH compartment, we used reovirus virions chemically
coupled to pHrodo, a pH sensitive dye. An increase in ﬂuorescence
of pHrodo-labeled reovirus during early stages of infection is
indicative of delivery of virus particles into a low pH environment
(Anafu et al., 2013; Mainou and Dermody, 2012). Consistent with
efﬁcient internalization of the particles, pHrodo ﬂuorescence
increased following infection in control or Ouabain-treated cells
(data not shown). Moreover, we observed a modest (15%), yet
signiﬁcant increase in the mean ﬂuorescence intensity of the
internalized virus 3 h following infection of Ouabain-treated cells
in comparison to untreated cells (Fig. 2C). Thus, in agreement with
previous observations, Ouabain treatment leads to a lowering of
the endosomal pH. Though pHrodo and other available pH
indicators display large differences in ﬂuorescence between neu-
tral and acidic pH, they exhibit only a small change in ﬂuorescence
at acidic pHs below pH 6. Thus, the modest increase in ﬂuores-
cence could be due to a small change in pH, low sensitivity of
pHrodo in that pH range, or both. Regardless, our results indicate
that in Ouabain-treated cells, reovirus particles trafﬁc through a
compartment with below-normal pH.
Ouabain inﬂuences reovirus infection at a step after ISVP formation
In the endosomal compartment, reovirus virions are disas-
sembled by the action of low pH-dependent cathepsin proteases to
form ISVPs (Ebert et al., 2002). To determine if Ouabain treatment
inﬂuences ISVP formation, we monitored cleavage of the reovirus
μ1 protein into the δ fragment over the ﬁrst few hours after
infection. We found that μ1 cleavage occurred with similar
kinetics both in control and Ouabain-treated cells (Fig. 3A). These
data indicate that Ouabain treatment does not affect ISVP forma-
tion. Together, the results presented thus far suggest that Ouabain
lowers the pH of the compartments accessed by reovirus during
cell entry and affects a step in reovirus infection subsequent to
ISVP formation.
In vitro treatment of reovirus virions with proteases results in
formation of ISVPs that are identical in composition to ISVPs
generated within infected cells (Baer et al., 1999; Borsa et al.,
1973; Chang and Zweerink, 1971; Ebert et al., 2002; Silverstein
et al., 1972; Sturzenbecker et al., 1987). The capacity of in vitro
generated ISVPs to efﬁciently attach to host cells and initiate
infection allowed us to directly test the impact of Ouabain on
infection by ISVPs using indirect immunoﬂuorescence. Since ISVPs
initiate infection with kinetics faster than those observed during
virus infection, these experiments were terminated at 8 h follow-
ing infection. We observed that infection initiated using ISVPs was
insensitive to Ouabain at concentrations up to 200 μM. A reduc-
tion in infectivity of ISVPs was observed in the presence of 500 μM
Ouabain (Fig. 3B). Comparison of our results here and those
presented in Fig. 1 indicate that ISVPs are sensitive to Ouabain
but to a lower extent than virions. Upon incubation of infected
cells for an extended time, we observed that the inhibitory effect
of Ouabain on infection by ISVPs was less marked at 12 h and
Ouabain did not inﬂuence infectivity of ISVPs by 18 h following
infection (Fig. 3B). Consistent with this timing, we observed that
though expression of the reovirus nonstructural protein σNS was
lower in Ouabain-treated cells at 6 h following infection with
ISVPs, the levels of σNS in cells were equivalent in control and
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Fig. 1. Ouabain inhibits reovirus infection. ATCC L929 cells (A) or CHO cells (B) were
pretreated with the indicated concentration of Ouabain. The cells were adsorbed with
103 particles per cell of T1L or 102 particles per cell of T1L/T3DM2. (B) CHO cells were
adsorbed with 105 particles per cell of T1L or 104 particles per cell of T1L/T3DM2. After
incubation at 37 1C for 18 h in the presence of the indicated concentration of Ouabain,
reovirus positive cells were identiﬁed by indirect immunoﬂuorescence. Infectivity
equivalent to the number of ﬂuorescent foci obtained in cells treated with 0 μM
Ouabain was considered 100%. Results are expressed as mean infectivity relative to
that obtained in the presence of 0 μM Ouabain for three independent samples. Error
bars indicate SD. *, Po0.05 as determined by Student's t-test in comparison to cells
treated with 0 μM Ouabain. (C) ATCC L929 cells pretreated with Ouabain were
adsorbed with 102 particles per cell of T1L/T3DM2. Titers of virus in cell lysates at
0 and 24 h in the presence of the indicated concentration of Ouabainwere determined
by plaque assay. Results are expressed as yield of virus for three independent samples.
Error bars indicate SD. *, Po0.05 as determined by Student's t-test in comparison to
cells treated with 0 μM Ouabain. (D) ATCC L929 cells were treated with the indicated
concentration of Ouabain for 18 h. Cell viability was assessed by CellTiter-Glo
chemiluminiscent assay. Results are expressed as mean relative light units for three
independent samples. Error bars indicate SD. (E) Bright ﬁeld images of cells treated
with 0 or 500 μM Ouabain for 18 h are shown. Scale bar indicates 100 μm.
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Ouabain-treated cells by 9–12 h following infection (Fig. 3C). These
data suggest that Ouabain treatment delays but does not prevent
infection by ISVPs.
The lowering of endosomal pH by Ouabain requires the function
of the vacuolar ATPase (Cain et al., 1989; Feldmann et al., 2007). Thus,
blockade of activity of the vacuolar ATPase should prevent Ouabain-
mediated decrease in the pH of cellular endosomes and therefore
diminish the effect of Ouabain treatment on infection with ISVPs. To
test this possibility, we determined whether Ouabain diminished the
infectivity of ISVPs in cells pretreated with vacuolar ATPase inhibitor,
Baﬁlomycin A1 (Yoshimori et al., 1991). Consistent with previous
studies and our results above, infection by ISVPs was not affected by
Baﬁlomycin A1 but diminished by Ouabain (Martinez et al., 1996). In
cells treated with Baﬁlomycin A1 prior to addition of Ouabain, the
infectivity of ISVPs was unaffected (Fig. 3D). These data further
suggest that inhibitory effect of Ouabain on infection is due to
lowering of the pH.
Ouabain affects ISVP-to-ISVP* conversion
The μ1 protein exposed on the surface of the ISVPs undergoes a
conformational change to form ISVP* and release pore forming μ1
fragments that facilitate the delivery of viral cores into the
cytoplasm (Chandran et al., 2003). As a consequence of these
events, viral cores begin RNA synthesis. To determine the effect of
Ouabain on viral RNA synthesis, we measured viral RNA synthesis
in ISVP infected cells using reverse transcription quantitative PCR
(RT-qPCR). In untreated cells, we detected an 1800-fold increase
inþstrand speciﬁc for the viral S1 gene segment. In contrast,
Ouabain treatment resulted in only an 60-fold increase (Fig. 4A).
These data suggest that Ouabain treatment affects viral RNA
synthesis, indicating that either ISVP-to-ISVP* conversion, core
delivery across membranes, RNA synthesis from cores, or each of
these steps are sensitive to Ouabain.
Due to the absence of outer-capsid proteins required for cell entry,
reovirus cores are noninfectious. However, cores transfected into cells
can bypass the usual cell entry events and complete the remaining
stages of virus infection (Jiang and Coombs, 2005). To identify if
Ouabain affects virus infection after the delivery of viral cores into the
cytoplasm, wemeasured infectivity of transfected reovirus cores in the
presence and absence of Ouabain. At 12 h, the ﬁrst time point at which
a signiﬁcant fraction of reovirus antigen-positive cells were detected
following transfection, the infectivity of cores was equivalent in the
presence and absence of Ouabain (Fig. 4B). In addition to the results
presented in Fig. 1D and E, the absence of an inhibitory effect of
Ouabain on establishment of infection by transfected cores rules out
the possibility that Ouabain treatment adversely affects the viability of
host cells. Moreover, the data demonstrating that infection initiated by
transfected cores is unaffected by Ouabain suggest that a step in
reovirus infection subsequent to ISVP formation but prior to core
transcription is affected by Ouabain treatment. These results point to
ISVP-to-ISVPn conversion or cytoplasmic delivery of cores as Ouabain-
sensitive events.
To directly test the effect of Ouabain on ISVP-to-ISVP* conver-
sion in infected cells, we stained infected cells with a monoclonal
antibody, 4A3, that detects μ1 in ISVP* but not in an ISVP
conformation (Chandran et al., 2003). Consistent with previous
studies, 4A3 did not label cells immediately following attachment
(0 h) (Fig. 4C) (Chandran et al., 2003). Upon infection of cells in the
absence of Ouabain for 2 h, we observed diffuse cytoplasmic
staining by 4A3 in 15% of cells (Fig. 4C and D). Because the
altered conformer of δ is released from core particles following
ISVP-to-ISVP* conversion and distributes into the cytoplasm of
infected cells, 4A3 positivity is indicative of ISVP* conversion
(Chandran et al., 2003). Following incubation of cells in the
presence of Ouabain, we found signiﬁcantly fewer 4A3-positive
cells. Thus, our studies demonstrate that Ouabain treatment
inhibits ISVP-to-ISVP*conversion.
Efﬁciency of ISVP-to-ISVP* conversion is diminished at low pH
Conversion of reovirus virions-to-ISVP and ISVP-to-ISVP* can
also be recapitulated in vitro. We therefore decided to determine
if in vitro conversion of ISVPs-to-ISVP*s is affected directly by
Ouabain or indirectly by the effect of Ouabain on the pH of the
endosomal compartment. Incubation of ISVPs at elevated tem-
peratures in vitro triggers their conversion to ISVP*s (Agosto et al.,
2007; Middleton et al., 2007; Sarkar and Danthi, 2013). ISVP-to-
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Fig. 2. Ouabain allows efﬁcient viral attachment, internalization and delivery into a low pH compartment. (A) ATCC L929 cells pretreated with 0 or 500 μM Ouabain were
adsorbed with 5104 particles per cell of T1L/T3DM2. Attached virions were detected by staining with anti-reovirus sera using a ﬂow cytometer. The results are expressed as
the mean percentage of reovirus-positive cells and the mean ﬂuorescence intensity for three independent samples. Error bars indicate SD. (B) ATCC L929 cells pretreated
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were ﬁxed and stained with anti-reovirus sera and Acti-stain. Mean intensity of reovirus antigen normalized to the area from 10 randomly selected cells is shown. Error bars
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Ouabain. Error bars indicate SD. *, Po0.05 as determined by Student's t-test in comparison to cells treated with 0 μM Ouabain.
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ISVP* conversion is characterized by conformational changes to the
particle-associated δ fragment that render the δ fragment sensi-
tive to proteases. We found that inclusion of Ouabain during
in vitro experiments did not affect the temperature at which δ
became protease sensitive (data not shown). These data suggest
that the inhibitory effect of Ouabain on ISVP* formation in cells is
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Fig. 3. Ouabain inﬂuences infection subsequent to ISVP formation. (A, B) ATCC L929
cells pretreated with 0 or 500 μMOuabain were adsorbed with 104 particles per cell
of T1L/T3DM2. Cell lysates prepared following infection in the presence of CHX and
the indicated concentration of Ouabain for various time intervals were immuno-
blotted for μ1 and PSTAIR loading control. μ1 resolves as μ1C on SDS-PAGE gels
(Nibert et al., 2005). (B) ATCC L929 cells pretreated with the indicated concentra-
tion of Ouabain were adsorbed with 103 ISVPs per cell of T1L/T3DM2. After
incubation at 37 1C for 8,12, or 18 h in the presence of the indicated concentration
of Ouabain, reovirus positive cells were identiﬁed by indirect immunoﬂuorescence.
Infectivity equivalent to the number of ﬂuorescent foci obtained in cells treated
with 0 μM Ouabain was considered 100%. Results are expressed mean infectivity
relative to that obtained in the presence of 0 μM Ouabain for three independent
samples. Error bars indicate SD. *, Po0.05 as determined by Student's t-test in
comparison to cells treated with 0 μM Ouabain. (C) ATCC L929 cells pretreated with
0 or 500 μM Ouabain were adsorbed with 103 ISVPs per cell of T1L/T3DM2. Cell
lysates prepared following infection in the presence of the indicated concentration
of Ouabain for various time intervals were immunoblotted for σNS and PSTAIR
loading control. (D) ATCC L929 cells pretreated with 0 or 200 nM Baﬁlomycin were
treated with 0 or 500 μM Ouabain. Cells were adsorbed with 103 ISVPs per cell of
T1L/T3DM2. After incubation at 37 1C for 8 h in the presence (þ) or absence () of
Baﬁlomycin, Ouabain or both, reovirus positive cells were identiﬁed by indirect
immunoﬂuorescence. Infectivity equivalent to the number of ﬂuorescent foci
obtained in cells treated with 0 μM Ouabain was considered 100%. Results are
expressed as mean infectivity relative to that obtained in the presence of 0 μM
Ouabain for three independent samples. Error bars indicate SD. *, Po0.05 as
determined by Student's t-test in comparison to cells treated with 0 μMOuabain. **,
Po0.05 as determined by Student's t-test in comparison to cells treated with
500 μM Ouabain.
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Fig. 4. Ouabain treatment diminishes efﬁciency of ISVP* formation. (A) ATCC L929
cells pretreated with 0 or 500 μM Ouabain were adsorbed with 104 ISVPs per cell of
T1L/T3DM2. Following incubation for 6 h in the presence of the indicated
concentration of Ouabain, RNA extracted from infected cells was subjected to RT-
qPCR for reovirus S1þstrand RNA and GAPDH mRNA at 0 and 6 h post-infection.
The results are presented as the mean fold increase in viral S1þstrand RNA over 6 h
for three independent samples. Error bars indicate SD. *, Po0.05 as determined by
Student's t-test in comparison to cells treated with 0 μM Ouabain. (B) ATCC L929
cells pretreated with 0 or 500 μM Ouabain were transfected with reovirus cores.
Infectivity 12 h following transfection was measured using indirect immunoﬂuor-
escence. Infectivity equivalent to the number of ﬂuorescent foci obtained in cells
treated with 0 μM Ouabain was considered 100%. Results are expressed as mean
infectivity relative to that obtained in the presence of 0 μM Ouabain for three
independent samples. Error bars indicate SD. (C) ATCC L929 cells pretreated with
0 or 500 μM Ouabain were adsorbed with 2.5104 ISVPs per cell of T1L. Following
incubation for 0 or 2 h in the presence of CHX and the indicated concentration of
Ouabain, the cells were ﬁxed, permeabilized, and immunostained with 4A3 and
DAPI. Scale bar indicates 20 μm (D) Percentage of total cells (DAPI positive) that also
stain with 4A3 at 2 h following infection were quantiﬁed by counting 150 cells
from randomly selected ﬁelds in three independent wells. No 4A3 positive cells
were detected at 0 h. *, Po0.05 as determined by Student's t-test in comparison to
cells treated with 0 μM Ouabain.
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not due to the direct effect on Ouabain on the virus capsid but
likely a consequence of Ouabain-mediated decrease in endosomal
pH. To directly test whether ISVP-to-ISVP* conversion is affected
by pH, ISVPs were placed in buffers of decreasing pHs and
triggered to form ISVP* by incubation at elevated temperatures.
CsCl-generated ISVP*s were used in parallel to control for protease
activity. We found that heat-triggered ISVP* formation occurs most
efﬁciently at pH 7.5. Further acidiﬁcation to a pH of 6.0 or 5.0,
reminiscent of the pH encountered in the early or late endosomes
(Ohkuma and Poole, 1978; Tycko and Maxﬁeld, 1982), required
increasingly higher temperatures to complete ISVP* formation
(Fig. 5A). Because the δ fragment of ISVP* generated using CsCl
as a trigger was protease-sensitive in buffers of each pH, these data
indicate that the effect of pH on the digestion susceptibility of δ
was a function of its conformation.
ISVP-to-ISVP* conversion in cells is likely triggered by interac-
tion of the exposed μ1 protein with a membrane component
(Chandran et al., 2002; Liemann et al., 2002). Therefore, incubation
of ISVPs with model membranes such as those of bovine erythro-
cytes results in ISVP-to-ISVP* conversion and the concomitant
release of μ1-derived pore-forming peptides under physiological
conditions (Agosto et al., 2006; Chandran et al., 2002; Sarkar and
Danthi, 2010, 2013). Because the released peptides perforate
erythrocyte membranes and cause hemolysis, hemolysis can be
used as a readout for the generation of ISVP*s (Agosto et al., 2006;
Chandran et al., 2002; Ivanovic et al., 2008). Though hemolysis
was signiﬁcantly less efﬁcient in citrate buffer than the Tris-based
buffer typically used for hemolysis (Sarkar and Danthi, 2010, 2013),
a signiﬁcant amount (25%) of hemolysis was observed at a pH of
7.5 (Fig. 5B). In contrast, minimal hemolysis was observed at a pH
of 5.0. Thus, hemolysis efﬁciency is diminished at acidic pH. To
rule out the possibility that the pore-forming activity of μ1
peptides is sensitive to pH, we assessed the capacity of ISVPs to
hemolyze erythrocytes under conditions where ISVP* formation is
efﬁcient. For these experiments, CsCl, was included in the hemo-
lysis reaction (Chandran et al., 2002). We observed that in the
presence of CsCl, hemolysis was equivalently efﬁcient at pH
7.5 and 5.0. These data indicate that pore formation by μ1-
derived peptides is not affected by acidic pH. Therefore, our
studies demonstrate that ISVP-to-ISVP* conversion is sensitive to
acidic pH.
Discussion
During entry of reovirus into host cells, ISVPs can be formed
intracellularly at low pH or extracellularly at neutral pH. Thus,
subsequent steps in reovirus replication including ISVP-to-ISVP*
conversion and pore formation to deliver viral cores can occur in
distinct environments. In this study, we investigated the effect of
pH on cell entry events that occur subsequent to ISVP formation.
We found that enhanced acidiﬁcation of cellular endosomes using
Ouabain diminishes the capacity of reovirus to initiate infection by
blocking ISVP-to-ISVP* conversion. In vitro conversion of ISVP-to-
ISVP* was also affected by low pH. Thus, our data indicate that the
efﬁciency with which reovirus initiates infection may depend on
the pH of the compartment where ISVP-to-ISVP* conversion
occurs.
How pH inﬂuences ISVP-to-ISVP* conversion is unknown.
During ISVP-to-ISVP* conversion, the μ1 protein undergoes struc-
tural changes that result in exposure of buried μ1 hydrophobic
regions and antibody epitopes (Chandran et al., 2002). Concomi-
tantly, the viral μ1N and ϕ fragments are released (Agosto et al.,
2006; Ivanovic et al., 2008). Trimers of μ1 form a stabilizing lattice
on the surface of ISVPs (Dryden et al., 1993; Hooper and Fields,
1996; Middleton et al., 2002; Wessner and Fields, 1993; Zhang
et al., 2005). The structural changes needed to complete ISVP-to-
ISVP* transition require disruption of interactions of μ1 molecules
within and between μ1 trimers, and between μ1 and the core
proteins (Agosto et al., 2007; Middleton et al., 2007; Sarkar and
Danthi, 2010, 2013; Zhang et al., 2006). It would therefore be
anticipated that pH affects ISVP* conversion by changing the
strength of one or more of these interactions between viral capsid
proteins.
Previously, it has been demonstrated that a reovirus mutant
that is inefﬁcient in the formation of ISVP* is less infectious and
ISVPs of this virus accumulate in a compartment positive for
lysosomal markers (Chandran et al., 2003). Localization of virions
or an entry intermediate to the lysosomes has also been reported
when viral uptake mechanisms or viral trafﬁcking routes are
perturbed in cells lacking the cytoplasmic tail of β1 integrins or
in cells treated with Src kinase inhibitors (Maginnis et al., 2008;
Mainou and Dermody, 2011). Because cathepsins should be active
in this compartment (Turk et al., 2012), we think it likely that the
particle trapped in the lysosomes is an ISVP. Why ISVPs fail to
escape lysosomes is not understood. Our results presented here
indicating that ISVPs cannot complete ISVP* formation efﬁciently
at low pH offer a possible explanation for these observations.
In many cell types, including the L929 cells used in our studies
here, ISVPs initiate infection much more readily than virions
(Golden et al., 2002). While in most cases, the poorer infectivity
of virions can be explained by the absence of sufﬁcient amounts of
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Fig. 5. Low pH affects ISVP-to-ISVP* conversion. (A) ISVPs in different buffers of the
indicated pH were heated at a range of temperatures between 33 1C and 50 1C for
20 min and treated with proteinase K at 4 1C for 30 min. Samples were resolved by
SDS-PAGE and stained using Coomassie Brilliant Blue. Virus (V), ISVP (I) and ISVP*
(I*) were resolved to indicate the protein composition of each type of particle. I*
samples were generated by heating ISVPs to 39.7 1C in the presence of 300 mM
CsCl (Chandran et al., 2002). This sample also serves as a control for efﬁcient
proteolysis under each buffer condition. The positions of reovirus capsid proteins
are shown. ϕ is too small to resolve on the gel. (B) ISVPs were incubated with
erythrocytes in buffers of the indicated pH with 0 mM or 300 mM CsCl. Hemolysis
was quantiﬁed by determining absorbance of the supernatant at 405 nm. Results
are expressed as mean percent hemolysis for three independent samples. Error
bars indicate SD. *, Po0.05 as determined by Student's t-test in comparison to
hemolysis at pH 7.5.
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mature cathepsins, a subset of these cell types are unable to
support virion infection despite the presence of mature cathepsins
(Golden et al., 2002). Thus, it is proposed that the nonpermissivity
of these cell lines is related to the absence of other host factors
needed for infection by virions. However, an alternate explanation
for this observation could be that these cell lines present an
environment that is restrictive to infection by viruses but not
ISVPs. L929 cells are among the most permissive to reovirus
infection and our data indicating that reovirus titers increase by
two orders of magnitude in 24 h support this idea (Fig. 1C). Thus, it
is unlikely that the deﬁciency in cathepsin activity contributes to
the lower infectivity of virions in comparison to ISVPs. Following
infection by virions, particles trafﬁc via early endosomes to late
endosomes (Boulant et al., 2013; Mainou and Dermody, 2012). In
contrast, depending on the cell type, following infection by ISVPs,
the particles either penetrate at the plasma membrane or are
internalized but exit the endocytic pathway prior to reaching early
endosomes (Borsa et al., 1979; Boulant et al., 2013; Lucia-Jandris
et al., 1993; Schulz et al., 2012). Thus, virions and ISVPs exit the
endosomal system from distinct pH environments. We therefore
propose that infection by virions is less efﬁcient because virions
convert to ISVPs in a low pH compartment where the next step in
the infection process – ISVP-to-ISVP* conversion is less efﬁcient.
While we did not attempt to identify which cellular membrane
is bypassed by ISVPs, the sensitivity of ISVPs to the pH lowering
effect of Ouabain is supportive of the idea that infection initiated
by ISVPs requires their internalization through a compartment
that contains both the Naþ/Kþ pump and the vacuolar ATPase.
Virions may be more sensitive to Ouabain than ISVPs because they
transit through a more distal compartment within the endosomal
uptake pathway that contains either more of the Naþ/Kþ pump,
more vacuolar ATPase, or both. In some cell types, ISVPs penetrate
the host membrane directly at the plasma membrane (Lucia-
Jandris et al., 1993). The lower sensitivity of ISVPs can therefore
also be explained by the possibility that a fraction of the ISVPs
enter directly at the plasma membrane and do not traverse a
compartment that has any Naþ/Kþ pumps or vacuolar ATPase
and consequently are not exposed to a low pH environment. Given
our in vitro data, we reasoned that ISVPs entering at the plasma
membrane could be blocked for ISVP* formation by initiating
infection in buffers of lower pHs. Though we attempted to initiate
infection of ISVPs in such conditions, the effect of low pH
treatment on cells for the amount of time needed to allow
initiation of infection by ISVPs severely compromised the health
of the cells and did not allow us to address this possibility.
Ouabain has been previously demonstrated to block infection
by a variety of enveloped viruses including Ebola virus, Herpes
Simplex virus, Sendai virus, Sindbis virus and Porcine Reproduc-
tive and Respiratory Syndrome virus (PRRSV) (Dodson et al., 2007;
Garcia-Dorival et al., 2014; Karuppannan et al., 2012; Mento and
Stollar, 1978; Nagai et al., 1972). In a majority of these studies, it
has been demonstrated that Ouabain treatment inhibits viral gene
expression. However, the stage at which Ouabain blocks viral
infection is not known. The inhibitory effect of Ouabain on
disparate viruses argues that Ouabain targets a cellular compo-
nent. In the current study we focused on the pH lowering effect of
Ouabain (Cain et al., 1989; Feldmann et al., 2007). Our analyses of
each stage of virus infection, the neutralization of the effect of
Ouabain by blocking the vacuolar ATPase, and in vitro analysis of
stages of viral entry indicate that enhanced acidiﬁcation of the
endosomes blocks reovirus infection. However, at least some of
the viruses (Herpesvirus and Sendai virus) that are sensitive to
Ouabain do not require endocytosis for cell entry (Fuller and Spear,
1987; White et al., 1980). Thus, it seems unlikely that the pH
lowering effect of Ouabain blocks infection by these viruses. In
addition to the endsomal pH, Ouabain can also affect endocytosis
and cellular signaling due to the inhibition of the Naþ/Kþ pump
(Feldmann et al., 2007; Haas et al., 2002; Liu et al., 2000; Wang
et al., 2004). Detailed analyses of how blockade of the Naþ/Kþ
pump inﬂuences infection by these viruses could aid in the deve-
lopment of antiviral agents against these pathogenic viruses.
Materials and methods
Cells
ATCC L929 cells were maintained in Eagle's MEM (EMEM)
(Lonza) supplemented to contain 5% fetal bovine serum (FBS)
(Invitrogen) and 2 mM L-glutamine (Invitrogen). Spinner-adapted
murine L929 cells were maintained in Joklik's MEM (Lonza)
supplemented to contain 5% FBS, 2 mM L-glutamine, 100 U/ml
penicillin (Invitrogen), 100 μg/ml streptomycin (Invitrogen), and
25 ng/ml amphotericin B (Sigma-Aldrich). CHO cells were main-
tained in HAM's F12 medium (Lonza) supplemented to contain
10% FBS and 2 mM L-glutamine. All experiments were performed
in ATCC L929 cells or CHO cells. Spinner-adapted L929 cells were
used for cultivating and purifying viruses.
Reagents
Ouabain octahydrate, Baﬁlomycin A1 and proteinase K were
purchased from Sigma-Aldrich. TLCK-treated Chymotrypsin (CHT)
and proteinase K was purchased from Worthington. Anti-reovirus
polyclonal antibodies, anti-μ1 4A3 mAb, and anti-σNS antibodies
were a gift from Dr. T. Dermody (Vanderbilt University).
Viruses
Puriﬁed reovirus virions were prepared using second- or third-
passage lysates stocks of recombinantly generated reovirus T1L or
T1L/T3DM2 (Kobayashi et al., 2010; Sarkar and Danthi, 2010). Viral
particles were Vertrel-XF (Dupont) extracted from infected cell
lysates, layered onto 1.2 to 1.4 g/cm3 CsCl gradients, and centri-
fuged at 187,183g for 4 h. Bands corresponding to virions (1.36 g/
cm3) were collected and dialyzed in virion-storage buffer (150 mM
NaCl, 15 mMMgCl2, 10 mM Tris–HCl [pH 7.4]) (Berard and Coombs,
2009). The concentration of reovirus particles in puriﬁed prepara-
tions was determined from an equivalence of one OD unit at
260 nm equals 2.11012 virions per ml (Smith et al., 1969). The
particle to PFU of ratios of each virus preparation used for
infections was between 200 and 400.
For pHrodo labeling, reovirus particles were diluted 10-fold
into fresh 0.05 M sodium bicarbonate buffer (pH 8.5) to attain a
ﬁnal concentration of 31012 particles/ml and incubated with
10 μM pHrodo Green STP (Invitrogen) at room temperature for
90 min in the dark. Virus particles were dialyzed against PBS and
stored at 4 1C.
Infections
Monolayers of ATCC L929 or CHO cells were pretreated with
media containing different concentrations of Ouabain at 37 1C for
1 h. Cells were washed with PBS, and adsorbed with virions or
ISVPs at 4 1C (for attachment and in cell ISVP formation) or room
temperature (for infectivity measurement, internalization, σNS
expression, and RNA synthesis) for 1 h. Cells were washed with
PBS and incubated in media containing different concentrations of
Ouabain at 37 1C for the indicated time intervals. For experiments
using Baﬁlomycin, the inhibitor was included in the pretreatment
media 1 h prior to Ouabain treatment and replaced in the media
following virus adsorption. For analyzing ISVP formation, media
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added post-adsorption also included 10 μg/ml cycloheximide.
Cycloheximide was used to ensure that signal from only incoming
viral proteins is detected. For attachment and internalization
assays, cells were detached using PBS supplemented with 20 mM
EDTA and virus adsorption was performed by continuous rotation.
MOIs for indirect immunoﬂuorescence were selected to obtain
200–1000 foci per ﬁeld of view. 1000 foci per ﬁeld represent 25%
of infected cells. Fewer particles were used for T1L/T3DM2 than
T1L because T1L/T3DM2 produces 10 times as many infected
cells as T1L. A higher dose of virus was used to infect CHO cells
because CHO cells are poorly permissive to reovirus due to the
absence of function JAM-A (Danthi et al., 2006). MOIs for other
experiments were selected based on the sensitivity of the
assay used.
Assessment of infectivity by indirect immunoﬂuorescence
Monolayers were ﬁxed with chilled methanol at 20 1C for a
minimum of 30 min, washed twice with PBS, blocked with 2.5% Ig-
free bovine serum albumin (BSA)(Invitrogen), and incubated with
polyclonal rabbit anti-reovirus serum at a 1:5000 dilution in PBS
containing 0.25% Triton X-100 (TX-100) at room temperature for
30 min. Monolayers were washed twice with PBS and incubated
with a 1:5000 dilution of Alexa Fluor 488-labeled anti-rabbit IgG
(Invitrogen) in PBS containing 0.25% TX-100. The infected cells
were visualized by indirect immunoﬂuorescence using an Olym-
pus IX71 microscope. Infected cells were identiﬁed by the pre-
sence of intense cytoplasmic ﬂuorescence that was excluded from
the nuclei. No background staining of uninfected control mono-
layers was observed. Reovirus antigen-positive cells were quanti-
ﬁed by counting ﬂuorescent cells in random ﬁelds in three
independent wells at a magniﬁcation of 20 .
To assess infectivity of viral cores, cells in each well of a 96 well
plate were transfected with 3.3108 cores using 0.05 μl of
Lipofectamine 2000 (Invitrogen). The transfection was incubated
at 37 1C for 12 h. Infectivity was assessed using indirect immuno-
ﬂuorescence as described above. Incubation of cells with an
equivalent number of cores without addition of lipofectamine
was used as a control and produced no reovirus-positive cells.
Growth assay
After removal of the inoculum, the cells were washed with PBS
and incubated at 37 1C for 0 h or 24 h. Cells were frozen and
thawed twice prior to determination of viral titer by plaque assay
using L929 cells. Viral yields were calculated according to the
following formula: Log10¼ log10(PFU/ml)24 h log10(PFU/ml)0 h.
Cell viability assay
Uninfected cells grown in black walled 96-well plates were
incubated with the indicated concentration of Ouabain for 18 h.
Cell lysates were prepared using Cell-titer Glo reagents (Promega)
according to manufacturer's instructions and luminescence was
measured using a Biotek Synergy H1 plate reader. Uninfected cells
grown in 96-well plates were incubated with the indicated
concentration of Ouabain for 18 h and imaged by light microscopy
using an Olympus IX71 microscope at 20 magniﬁcation.
Assessment of viral attachment by ﬂow cytometry
After removal of the inoculum, the cells were harvested and
resuspended in PBS supplemented with 5% BSA (PBS–BSA). Reo-
virus speciﬁc rabbit polyclonal antiserum at 1:2500 was added and
incubated at 4 1C for 30 min with continuous rotation. The cells
were washed twice with PBS–BSA followed by incubation at 4 1C
for 30 min with the Alexa ﬂuor 488-labeled goat anti rabbit
antibody at 1:1000 in PBS–BSA with continuous rotation. The cells
were washed twice with PBS–BSA prior to being ﬁxed with cold 1%
paraformaldehyde in PBS. Viral attachment to cells was quantiﬁed
using BD FACSCalibur Cell Analyzer and the CellQuestPro software.
Measurement of reovirus internalization
ATCC L929 cells plated on coverslips were washed with chilled
PBS and then pretreated with the indicated concentration of
Ouabain and 10 μg/ml cycloheximide at 37 1C for 1 h. Cells were
adsorbed at 4 1C for 1 h with T1L/T3DM2 virus (8105 particles/
cell). Media containing the indicated concentration of Ouabain and
10 μg/ml cycloheximide was added and incubated for 3 h. Cells
were washed with PBS and ﬁxed with 4% formaldehyde for 20 min
at room temperature. Excess formaldehyde was quenched with an
equal amount of 0.1 M glycine, followed by washing with PBS.
Cells were treated with 1% Triton X-100 for 5 min and incubated
with PBS-BGT (PBS, 0.5% BSA, 0.1% glycine, and 0.05% Tween 20)
for 10 min. Cells were incubated with reovirus-speciﬁc polyclonal
antiserum (1:2000) in PBS-BGT for 1 h and washed with PBS-BGT.
Cells were stained for 1 h with donkey anti-rabbit immunoglobu-
lin conjugated to Alexa594 (Molecular probes) and Acti-stain
(Cytoskeleton, Inc) to visualize actin. Coverslips were removed
and placed on slides with Aqua Polymount (Polysciences, Inc.).
Images were captured on a Leica laser-scanning confocal micro-
scope using LAS-AF software. The intensity of reovirus stain in an
area of the cells internal to the boundary marked by Acti-stain was
quantiﬁed using the LAS-AF software.
Assessment of pHrodo ﬂuorescence intensity by ﬂow cytometry
After removal of the inoculum, cells were washed with PBS, and
resuspended in pre-warmed EMEM containing 0 or 500 μM
Ouabain. The cells were placed back in plates and incubated at
37 1C for 3 h to allow for internalization. The attached and
unattached cells were collected with PBS-EDTA and resuspended
in cold 1% paraformaldehyde in PBS. Fluorescence emitted by the
pHrodo-labeled virus was quantiﬁed using BD FACSCalibur Cell
Analyzer and the CellQuestPro software.
Evaluating ISVP-to-ISVP* formation in cells
ATCC L929 cells plated in 96 well plates were washed with chilled
PBS and then pretreated at 37 1C with indicated concentration of
Ouabain and 10 μg/ml cycloheximide for 1 h. Cells were adsorbed at
4 1C for 1 h with T1L ISVP with 104 particles per cell. Media
containing indicated concentration of Ouabain and 10 μg/ml cyclo-
heximide was added and incubated for 0 or 2 h. Cells were washed
with PBS and ﬁxed with 4% formaldehyde at room temperature for
20 min. Excess formaldehyde was quenched with an equal amount of
0.1 M glycine, followed by washing with PBS. Cells were treated with
1% Triton X-100 for 5 min and incubated with PBS-BGT (PBS, 0.5%
BSA, 0.1% glycine, and 0.05% Tween 20) for 10 min. Cells were
incubated with reovirus-speciﬁc 4A3 antiserum (1:500) in PBS-BGT
for 1 h and washed with PBS-BGT three times. Cells were stained
with anti-mouse IgG conjugated to Alexa 594 (Molecular probes) and
DAPI for 1 h and washed with PBS-BGT three times. The infected cells
were visualized by indirect immunoﬂuorescence using an Olympus
IX71 microscope. Reovirus antigen-positive cells were quantiﬁed by
counting ﬂuorescent cells in random ﬁelds in three independent
wells at a magniﬁcation of 20 .
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Generation of ISVPs and cores in vitro
ISVPs of T1L or T1L/T3DM2 were generated by incubation of
21012 virions or 21013 virions with 200 mg/ml of CHT in a total
volume of 0.1 ml at 32 1C in virion storage buffer or Sodium Citrate
buffer (150 mM NaCl, 15 mM sodium citrate [pH 7.5]) for 60 min
(Nibert et al., 1995). Proteolysis was terminated by addition of
2 mM phenylmethylsulphonyl ﬂuoride (PMSF) and incubation of
reactions on ice. Viral cores were generated by incubating 21013
particles with 200 μg/ml TLCK-treated CHT and 400 mM CsCl in a
total volume of 0.05 ml at 37 1C for 2 h. Proteolysis was terminated
by addition of 2 mM PMSF. Cores were dialyzed against PBS prior
to use. Generation of ISVPs or cores was conﬁrmed by SDS-
polyacrylamide gel electrophoresis (PAGE) and Coomassie Brilliant
Blue staining.
Preparation of infected cell lysates and immunoblotting
Cells were harvested, washed with PBS, and lysed using RIPA
lysis buffer (50 mM Tris [pH 7.5], 50 mM NaCl, 1% TX-100, 1% DOC,
0.1% SDS, and 1 mM EDTA) containing a protease inhibitor cocktail
(Roche), 500 μMDTT and 500 μM PMSF followed by centrifugation
at 13,000 rpm at 4 1C for 5 min to remove cell debris. The clariﬁed
lysates were subjected to immunoblot analysis.
The cell lysates were resolved by electrophoresis in SDS-PAGE
gels and transferred to nitrocellulose membranes. Membranes
were blocked for at least 1 h in blocking buffer (TBS containing
5% milk or 2.5% BSA) and incubated with anti-reovirus polyclonal
antibody (1:1000) or σNS (1:2000 each) and PSTAIR (1:10,000) at
4 1C overnight. Membranes were washed three times for 5 min
each with washing buffer (TBS containing 0.1% Tween-20) and
incubated with 1:20,000 dilution of Alexa Fluor conjugated goat
anti-rabbit IgG (for reovirus polyclonal), anti-mouse IgG (for
PSTAIR), or IRDye-conjugated anti-guinea pig IgG (for σNS) in
blocking buffer. Following three washes, membranes were
scanned using an Odyssey Infrared Imager (LI-COR).
RT-qPCR
RNA was extracted from infected cells using Tri-reagent (Mole-
cular Research Center). 0.5 to 2 μg of RNA was reverse transcribed
using gene-speciﬁc primers complementary to T1L S1 and GAPDH
mRNA using High Capacity cDNA Reverse Transcription Kit
(Applied Biosystems). A 1:10 dilution of the cDNA was subjected
to PCR using SYBR Select Master Mix (Applied Biosystems). ΔCt
values for each cDNA sample were calculated by subtracting Ct
values for GAPDH from Ct values of T1L S1. Fold change in gene
expression with respect to samples harvested at 0 h following
infection was measured using the ΔΔCt method (Schmittgen and
Livak, 2008).
In vitro ISVP-to-ISVP* conversion
To assess the effect on Ouabain on in vitro ISVPn formation,
ISVPs of T1L/T3DM2 at a concentration of 21012 per ml reaction
were diluted 1:10 into sodium citrate buffer (150 mM NaCl, 15 mM
sodium citrate [pH 7.5]) with 2 mM PMSF and with 0 or 500 mM
Ouabain. To assess the effect of pH on ISVPn formation, ISVPs of
T1L/T3DM2 at a concentration of 21012 per ml reaction were
diluted 1:10 into Sodium Citrate buffers (150 mM NaCl, 15 mM
sodium citrate) of pH 5.0, 6.0, or 7.5 containing 2 mM PMSF. The
reaction was divided into aliquots and incubated at temperatures
ranging from 33 1C to 50 1C in a gradient thermal cycler for 20 min,
transferred to ice for 20 min, and incubated with 30 μg/ml
proteinase K at 4 1C for 30 min. Proteinase K digestion was
terminated by addition of SDS-PAGE loading buffer and boiling
the samples at 95 1C for 5 min. Generation of ISVP*s was conﬁrmed
by SDS-PAGE and Coomassie Brilliant Blue staining.
Hemolysis
Citrated calf red blood cells (RBCs) (Colorado Serum Company)
were washed extensively with chilled PBS supplemented to con-
tain 2 mM MgCl2 (PBS-Mg) and resuspended at a concentration of
30% v/v in PBS-Mg. Hemolysis efﬁciency was analyzed by mixing a
2.22 μl aliquot of resuspended RBCs with T1L/T3DM2 ISVPs in a
total volume of 22.22 μl sodium citrate buffer at the desired pH in
the presence of 0 or 300 mM CsCl, followed by incubation at 37 1C
for 60 min. RBCs mixed with sodium citrate buffers without ISVPs
or with 1% Triton X-100 (TX-100) were used as control for 0 and
100% lysis, respectively. Samples were placed on ice for 30 min to
prevent further hemolysis and centrifuged at 500g at 4 1C for
3 min. The extent of hemoglobin release was quantiﬁed by
measuring the A405 of a 1:5 dilution of the supernatant in a
microplate reader (Molecular Devices). Percentage hemolysis was
calculated using the following formula: % hemolysis¼100 (Asam-
pleAbuffer)/(ATX-100Abuffer).
Statistical analysis
Statistical signiﬁcance between experimental groups was
determined using the unpaired t test function of the Graphpad
Prism software. P values less than 0.05 were considered to be
signiﬁcant and are indicated by asterix (n).
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